Songren Shu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming Medical University, Fu Wai Hospital · ORCID：0000-0001-8659-197X

发表论文 36 篇 · 总被引 540 次 · h-index 11

代表论文

• Gut microbiota‐derived butyric acid regulates calcific aortic valve disease pathogenesis by modulating GAPDH lactylation and butyrylation (2025 · iMeta · 被引 69)
• Promising dawn in the management of pulmonary hypertension: The mystery veil of gut microbiota (2024 · iMeta · 被引 30)
• Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy (2024 · BMC Medicine · 被引 25)
• Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy (2024 · Metabolism · 被引 22)
• The Challenge in Burden of Pulmonary Arterial Hypertension: A Perspective From the Global Burden of Disease Study (2025 · MedComm · 被引 10)
• Cutting-edge microneedle innovations: Transforming the landscape of cardiovascular and metabolic disease management (2024 · iScience · 被引 10)